Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

By David M. Thomas, R. Henshaw, K. Skubitz, S. Chawla, A. Staddon, J. Blay, M. Roudier, Judy Smith, Z. Ye, W. Sohn and 2 more. The Lancet Oncology, 2010

662 citations recorded by the source corpus.

Subfields: Molecular Biology, Oral Surgery, Rheumatology

View Paper: https://www.semanticscholar.org/paper/2f40dceae649c467d01dab685e529b002e923d86